- Release Date: 10/04/24 08:26
- Summary: Patient Dosing Milestone Achieved in Phase 2 Stroke Trial
- Price Sensitive: Yes
- Download Document 275.78KB
Ann: Patient Dosing Milestone Achieved in Phase 2 Stroke Trial
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AGN (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
84.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $104.5M | |||
| Open | High | Low | Value | Volume |
| 85.0¢ | 86.0¢ | 82.8¢ | $749.1K | 914.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 5000 | 82.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 84.5¢ | 8555 | 1 |
View Market Depth
| Last trade - 16.10pm 04/07/2024 (20 minute delay) ? |
| AGN (ASX) Chart |